Target
BCR/ABL p210 fusion protein
Ligand
BDBM50211223
Substrate
n/a
Meas. Tech.
ChEMBL_1636131 (CHEMBL3879029)
EC50
<100±n/a nM
Citation
 Wang, QLiu, FWang, BZou, FQi, ZChen, CYu, KHu, CQi, SWang, WHu, ZLiu, JWang, WWang, LLiang, QZhang, SRen, TLiu, QLiu, J Discovery of 4-Methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((1-nicotinoylpiperidin-4-yl)oxy)benzamide (CHMFL-ABL/KIT-155) as a Novel Highly Potent Type II ABL/KIT Dual Kinase Inhibitor with a Distinct Hinge Binding. J Med Chem 60:273-289 (2017) [PubMed]  Article 
Target
Name:
BCR/ABL p210 fusion protein
Synonyms:
BCR/ABL | BCR/ABL p210 fusion protein | fusion
Type:
PROTEIN
Mol. Mass.:
10728.88
Organism:
Homo sapiens (Human)
Description:
ChEMBL_102433
Residue:
97
Sequence:
QMLTNSCVKLQTVHSIPLTINKEEALQRPVASDFEPQGLSEAARWNSKENLLAGPSENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWC
  
Inhibitor
Name:
BDBM50211223
Synonyms:
CHEMBL3939150
Type:
Small organic molecule
Emp. Form.:
C33H38F3N5O3
Mol. Mass.:
609.6817
SMILES:
CN1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc2ccc(C)c(OC3CCN(CC3)C(=O)c3ccc(C)nc3)c2)CC1
Structure:
Search PDB for entries with ligand similarity: